 Cyclacel Pharmaceuticals, Inc. NASDAQ:CYCC Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Irina Koffler - LifeSci Advisors Spiro Rombotis - President, CEO Executive Director Paul McBarron - EVP, CFO, COO, Secretary Executive Director Mark Kirschbaum - SVP Chief Medical Officer Conference Call Participants Kevin DeGeeter - Oppenheimer Ahu Demir - Ladenburg Thalmann Co. Jonathan Aschoff - ROTH Capital Partners Operator Good afternoon, and welcome to the Cyclacel Pharmaceuticals First Quarter 2022 Results Conference Call and Webcast. Operator Instructions. 